Evidence map›Paper›PMID 34326154›Full record

ArticleBMJ open respiratory research2021

Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study.

Malte Kohns Vasconcelos, Katherine Loens, Louise Sigfrid, Elias Iosifidis, Cristina Epalza, Daniele Donà, Veerle Matheeussen, Savvas Papachristou, Emmanuel Roilides, Manuel Gijon and 32 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open respiratory research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 14 countries.

Malte Kohns VasconcelosPaediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George's, University of London, London, UK mkohns@sgul.ac.uk.ORCID 0000-0002-6207-9442
Katherine LoensLaboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.
Louise SigfridCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Elias IosifidisInfectious Diseases Unit, 3rd Department of Paediatrics, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece.
Cristina EpalzaPaediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario 12 de Octubre and Red de Investigación Traslacional en Infectología Pediátrica (RITIP), Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain.
Daniele DonàDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University Hospital of Padua, Padova, Italy.
Veerle MatheeussenLaboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.
Savvas PapachristouInfectious Diseases Unit, 3rd Department of Paediatrics, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece.
Emmanuel RoilidesInfectious Diseases Unit, 3rd Department of Paediatrics, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece.
Manuel GijonPaediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario 12 de Octubre and Red de Investigación Traslacional en Infectología Pediátrica (RITIP), Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain.
Pablo RojoPaediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Universitario 12 de Octubre and Red de Investigación Traslacional en Infectología Pediátrica (RITIP), Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain.
Chiara MinottiDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University Hospital of Padua, Padova, Italy.
Liviana Da DaltPaediatric Emergency Department, Department of Women's and Children's Health, University Hospital of Padua, Padova, Italy.
Samsul IslamPaediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George's, University of London, London, UK.
Jessica JarvisPaediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George's, University of London, London, UK.ORCID 0000-0002-8591-5378
Aggeliki Syggelou2nd Department of Paediatrics, National and Kapodistrian University of Athens (NKUA) School of Medicine, P. and A. Kyriakou Children's Hospital, Athens, Greece.
Maria Tsolia2nd Department of Paediatrics, National and Kapodistrian University of Athens (NKUA) School of Medicine, P. and A. Kyriakou Children's Hospital, Athens, Greece.
Maggie Nyirenda Nyang'waPaediatric Department, University Hospital Lewisham, Lewisham and Greenwich NHS Trust, London, UK.
Sophie KeersPaediatric Department, University Hospital Lewisham, Lewisham and Greenwich NHS Trust, London, UK.
Hanna RenkDepartment of Paediatric Cardiology, Pulmonology and Intensive Care Medicine, University Children's Hospital Tübingen, Tübingen, Germany.
Anna-Lena GemmelDepartment of Paediatric Cardiology, Pulmonology and Intensive Care Medicine, University Children's Hospital Tübingen, Tübingen, Germany.
Carmen D'AmoreClinical Pathways and Epidemiology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Marta Ciofi Degli AttiClinical Pathways and Epidemiology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Carmen Rodríguez-Tenreiro SánchezTranslational Paediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Servizo Galego de Saude, Santiago de Compostela, Spain.
Federico Martinón-TorresTranslational Paediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Servizo Galego de Saude, Santiago de Compostela, Spain.
Sigita BurokienėClinic of Children's Diseases, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
Tessa GoetghebuerDepartment of Paediatrics, St-Pierre Hospital Brussels, Brussels, Belgium.
Vana Spoulou1st Department of Paediatrics, National and Kapodistrian University of Athens (NKUA) School of Medicine, Agia Sophia Children's Hospital of Athens, Athens, Greece.
Andrew RiordanDepartment of Paediatric Infectious Diseases, Alder Hey Children's Hospital, Liverpool, UK.
Cristina CalvoPaediatrics and Infectious Diseases Department, La Paz University Hospital, Madrid, Spain.
Despoina GkentziDepartment of Paediatrics, University General Hospital of Patras, Patras Medical School, Patras, Greece.
Markus HufnagelDivision of Paediatric Infectious Diseases and Rheumatology, Department of Paediatrics and Adolescent Medicine, University Medical Centre, Medical Faculty, University of Freiburg, Freiburg, Germany.
Peter J OpenshawNational Heart and Lung Division, Faculty of Medicine, Imperial College London, London, UK.
Menno D de JongDepartment of Medical Microbiology, Amsterdam UMC, Amsterdam, The Netherlands.
Marion KoopmansDepartment of Viroscience, ErasmusMC, Rotterdam, The Netherlands.
Herman GoossensLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Margareta IevenLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Pieter L A FraaijSophia Children's Hospital, ErasmusMC, Rotterdam, The Netherlands.
Carlo GiaquintoDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University Hospital of Padua, Padova, Italy.
Julia A BielickiPaediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George's, University of London, London, UK.
Peter HorbyCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Michael SharlandPaediatric Infectious Diseases Research Group, Institute for Infection and Immunity, St. George's, University of London, London, UK.
St George's, University of London · GBUniversity of Antwerp · BEUniversity of Padua · ITHippocration General Hospital · GRNational and Kapodistrian University of Athens · GRResearch Institute Hospital 12 de Octubre · ESAngkor Hospital for Children · KHErasmus MC · NLPathways Behavioral Services · USUniversidade de Santiago de Compostela · ESUniversity Children's Hospital Tübingen · DEUniversity Hospital Lewisham · GBAmsterdam University Medical Centers · NLCentre Hospitalier Universitaire de Saint-Pierre · BEGeneral University Hospital of Patras · GRHospital Universitario La Paz · ESLung Institute · USUniversity of Freiburg · DEUniversity of Liverpool · GBVilnius University · LT

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundBoth pathogenic bacteria and viruses are frequently detected in the nasopharynx (NP) of children in the absence of acute respiratory infection (ARI) symptoms. The aim of this study was to estimate the aetiological fractions for ARI hospitalisation in children for respiratory syncytial virus (RSV) and influenza virus and to determine whether detection of specific respiratory pathogens on NP samples was associated with ARI hospitalisation.

methods349 children up to 5 years of age hospitalised for ARI (following a symptom-based case definition) and 306 hospital controls were prospectively enrolled in 16 centres across seven European Union countries between 2016 and 2019. Admission day NP swabs were analysed by multiplex PCR for 25 targets.

resultsRSV was the leading single cause of ARI hospitalisations, with an overall population attributable fraction (PAF) of 33.4% and high seasonality as well as preponderance in younger children. Detection of RSV on NP swabs was strongly associated with ARI hospitalisation (OR adjusted for age and season: 20.6, 95% CI: 9.4 to 45.3). Detection of three other viral pathogens showed strong associations with ARI hospitalisation: influenza viruses had an adjusted OR of 6.1 (95% CI: 2.5 to 14.9), parainfluenza viruses (PIVs) an adjusted OR of 4.6 (95% CI: 1.8 to 11.3) and metapneumoviruses an adjusted OR of 4.5 (95% CI: 1.3 to 16.1). Influenza viruses had a PAF of 7.9%, PIVs of 6.5% and metapneumoviruses of 3.0%. In contrast, most other pathogens were found in similar proportions in cases and controls, including

conclusionRSV is the predominant cause of ARI hospitalisations in young children in Europe and its detection, as well as detection of influenza virus, PIV or metapneumovirus, on NP swabs can establish aetiology with high probability. PAFs for RSV and influenza virus are highly seasonal and age dependent.

Indexed as

Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsCase-Control StudiesChild, PreschoolHospitalizationHumansclinical epidemiologypaediatric lung disaesepneumoniarespiratory infectionviral infection

Identifiers

PMID34326154
PMCPMC8323363
OpenAlexW3184200749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.